

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of other organism (GO:0098543) | 4.60784231 |
| 2 | detection of molecule of bacterial origin (GO:0032490) | 4.56007908 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.39039705 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38033991 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.28127918 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.28127918 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.28127918 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.28127918 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.28127918 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.28127918 |
| 11 | detection of bacterium (GO:0016045) | 4.20408259 |
| 12 | detection of external biotic stimulus (GO:0098581) | 4.15339835 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.04331457 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00813030 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92227740 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.92227740 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85299888 |
| 18 | detection of biotic stimulus (GO:0009595) | 3.81014946 |
| 19 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.69052149 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60979023 |
| 21 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.60472862 |
| 22 | neutrophil mediated immunity (GO:0002446) | 3.54683628 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.51532154 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 3.45190494 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.43889419 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41953034 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 3.41356831 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 3.39760042 |
| 29 | negative regulation of cell killing (GO:0031342) | 3.36967018 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.36967018 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.36715671 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.29555937 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.27726496 |
| 34 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.26712882 |
| 35 | regulation of interferon-alpha production (GO:0032647) | 3.25752490 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.23294813 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.22962264 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 3.20967182 |
| 39 | regulation of tolerance induction (GO:0002643) | 3.12863976 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11083593 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.07502215 |
| 42 | regulation of leukocyte degranulation (GO:0043300) | 3.06540711 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05417856 |
| 44 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02931218 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02660087 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.01408636 |
| 47 | pinocytosis (GO:0006907) | 2.98982597 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98193743 |
| 49 | response to laminar fluid shear stress (GO:0034616) | 2.95470112 |
| 50 | defense response to protozoan (GO:0042832) | 2.94879891 |
| 51 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94569816 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 2.94020660 |
| 53 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.92815917 |
| 54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92076183 |
| 55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90806272 |
| 56 | embryonic process involved in female pregnancy (GO:0060136) | 2.89117551 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88531474 |
| 58 | positive regulation of interferon-beta production (GO:0032728) | 2.84864168 |
| 59 | T cell migration (GO:0072678) | 2.84830660 |
| 60 | natural killer cell mediated immunity (GO:0002228) | 2.83779737 |
| 61 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.83779737 |
| 62 | regulation of mast cell activation (GO:0033003) | 2.78546954 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78171263 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 2.77539561 |
| 65 | regulation of cholesterol storage (GO:0010885) | 2.76723656 |
| 66 | regulation of B cell differentiation (GO:0045577) | 2.75897766 |
| 67 | T cell selection (GO:0045058) | 2.75188986 |
| 68 | regulation of macrophage cytokine production (GO:0010935) | 2.75037002 |
| 69 | B cell receptor signaling pathway (GO:0050853) | 2.74953215 |
| 70 | response to peptidoglycan (GO:0032494) | 2.72632572 |
| 71 | leukocyte aggregation (GO:0070486) | 2.72048438 |
| 72 | I-kappaB phosphorylation (GO:0007252) | 2.71277950 |
| 73 | B cell mediated immunity (GO:0019724) | 2.71274933 |
| 74 | response to protozoan (GO:0001562) | 2.71098969 |
| 75 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.70610677 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70183676 |
| 77 | negative regulation of type 2 immune response (GO:0002829) | 2.69643086 |
| 78 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.68805942 |
| 79 | neutrophil activation (GO:0042119) | 2.68606652 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68020737 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68020737 |
| 82 | negative regulation of B cell proliferation (GO:0030889) | 2.66257854 |
| 83 | T-helper 1 type immune response (GO:0042088) | 2.65978581 |
| 84 | hepatocyte apoptotic process (GO:0097284) | 2.65673523 |
| 85 | cellular response to interleukin-15 (GO:0071350) | 2.65084988 |
| 86 | cytokine secretion (GO:0050663) | 2.64313757 |
| 87 | granulocyte activation (GO:0036230) | 2.63096478 |
| 88 | response to host immune response (GO:0052572) | 2.62984961 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62984961 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 2.60671547 |
| 91 | growth hormone receptor signaling pathway (GO:0060396) | 2.54987731 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54516643 |
| 93 | regulation of response to interferon-gamma (GO:0060330) | 2.54122837 |
| 94 | positive regulation of histone deacetylation (GO:0031065) | 2.53112308 |
| 95 | germinal center formation (GO:0002467) | 2.52439975 |
| 96 | response to host (GO:0075136) | 2.52238282 |
| 97 | response to host defenses (GO:0052200) | 2.52238282 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52238282 |
| 99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52068391 |
| 100 | myeloid dendritic cell activation (GO:0001773) | 2.51469861 |
| 101 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.50902767 |
| 102 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50887079 |
| 103 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50394241 |
| 104 | B cell homeostasis (GO:0001782) | 2.50355732 |
| 105 | cellular extravasation (GO:0045123) | 2.49349322 |
| 106 | endothelial tube morphogenesis (GO:0061154) | 2.47235060 |
| 107 | morphogenesis of an endothelium (GO:0003159) | 2.47235060 |
| 108 | regulation of integrin activation (GO:0033623) | 2.46198026 |
| 109 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.44666407 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.43192455 |
| 111 | negative thymic T cell selection (GO:0045060) | 2.42562724 |
| 112 | leukocyte cell-cell adhesion (GO:0007159) | 2.42155804 |
| 113 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.41850169 |
| 114 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.41360279 |
| 115 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39864547 |
| 116 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.39223256 |
| 117 | thymic T cell selection (GO:0045061) | 2.38906889 |
| 118 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.38209241 |
| 119 | microglial cell activation (GO:0001774) | 2.35178900 |
| 120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.34296377 |
| 121 | response to type I interferon (GO:0034340) | 2.34196307 |
| 122 | tolerance induction (GO:0002507) | 2.33592950 |
| 123 | positive regulation of p38MAPK cascade (GO:1900745) | 2.33482520 |
| 124 | respiratory burst (GO:0045730) | 2.33166592 |
| 125 | regulation of interferon-beta production (GO:0032648) | 2.32239554 |
| 126 | negative T cell selection (GO:0043383) | 2.31617536 |
| 127 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.31545789 |
| 128 | nuclear pore complex assembly (GO:0051292) | 2.30909046 |
| 129 | cell adhesion mediated by integrin (GO:0033627) | 2.30150558 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 2.29902766 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.29161949 |
| 132 | cellular response to type I interferon (GO:0071357) | 2.29161949 |
| 133 | natural killer cell differentiation (GO:0001779) | 2.26986911 |
| 134 | response to interleukin-15 (GO:0070672) | 2.26981428 |
| 135 | regulation of necroptotic process (GO:0060544) | 2.25943923 |
| 136 | macrophage activation (GO:0042116) | 2.25314132 |
| 137 | negative regulation of interleukin-6 production (GO:0032715) | 2.24857531 |
| 138 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.24777661 |
| 139 | positive T cell selection (GO:0043368) | 2.24631657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.91637447 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.86407622 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.79470053 |
| 4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.77584960 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.61109664 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.54625530 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22686490 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.88753587 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86711140 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86144373 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75052986 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51468291 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50420109 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.46864650 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.44183497 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42989677 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42736038 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.26883007 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12159216 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11488054 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10855200 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10513198 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08024053 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06932015 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.05831097 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.97983336 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96934060 |
| 28 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94867713 |
| 29 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91543920 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.79955029 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79265921 |
| 32 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79003985 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78932909 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74679551 |
| 35 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68718905 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.65597651 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64788817 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.63418685 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60410309 |
| 40 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59735443 |
| 41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.58179024 |
| 42 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.52051158 |
| 43 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51771700 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51506615 |
| 45 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.48551259 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46666656 |
| 47 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46565240 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45708082 |
| 49 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.44313050 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41752043 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38701138 |
| 52 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33630634 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31789849 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31517924 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30930156 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29218228 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27446074 |
| 58 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26761192 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22880824 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22203955 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20881199 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19494099 |
| 63 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16559162 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14051520 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12947048 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12280698 |
| 67 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12163970 |
| 68 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11230547 |
| 69 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11230547 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10948632 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10376704 |
| 72 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09622781 |
| 73 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09314674 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08794830 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08529101 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07845444 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07354691 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06528606 |
| 79 | * MAF_26560356_Chip-Seq_TH2_Human | 1.06250489 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06021838 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05942358 |
| 82 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05704525 |
| 83 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.05330805 |
| 84 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.05330805 |
| 85 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.05330805 |
| 86 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05006070 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04905956 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04066531 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01271479 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00227517 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00079268 |
| 92 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99241163 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98718224 |
| 94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98668288 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98480979 |
| 96 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.97600796 |
| 97 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97577807 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97350496 |
| 99 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96322924 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96265532 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96115326 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96100446 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95471950 |
| 104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94810458 |
| 105 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93805558 |
| 106 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93546539 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92698970 |
| 108 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92361909 |
| 109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91942487 |
| 110 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90083222 |
| 111 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90016406 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89341342 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88941036 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88933439 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88845278 |
| 116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88323517 |
| 117 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88277664 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86708599 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85890879 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85873549 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85027699 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83603753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.26995369 |
| 2 | MP0003303_peritoneal_inflammation | 3.15318413 |
| 3 | MP0003436_decreased_susceptibility_to | 2.54319661 |
| 4 | MP0000685_abnormal_immune_system | 2.52304120 |
| 5 | * MP0001800_abnormal_humoral_immune | 2.48425484 |
| 6 | MP0005387_immune_system_phenotype | 2.40988662 |
| 7 | MP0001790_abnormal_immune_system | 2.40988662 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.33562929 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.32142352 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.27446264 |
| 11 | MP0008260_abnormal_autophagy | 2.21839650 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.15563186 |
| 13 | MP0005076_abnormal_cell_differentiation | 2.11610161 |
| 14 | MP0002419_abnormal_innate_immunity | 2.05377045 |
| 15 | MP0009278_abnormal_bone_marrow | 2.00694772 |
| 16 | * MP0002723_abnormal_immune_serum | 2.00465579 |
| 17 | MP0004510_myositis | 1.98537662 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.96859665 |
| 19 | MP0004947_skin_inflammation | 1.95013966 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.94466430 |
| 21 | MP0005025_abnormal_response_to | 1.91457912 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.91239110 |
| 23 | * MP0001819_abnormal_immune_cell | 1.89545887 |
| 24 | * MP0002420_abnormal_adaptive_immunity | 1.89477444 |
| 25 | MP0005451_abnormal_body_composition | 1.80001775 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.76121526 |
| 27 | MP0005671_abnormal_response_to | 1.75478207 |
| 28 | MP0009785_altered_susceptibility_to | 1.74854409 |
| 29 | MP0010307_abnormal_tumor_latency | 1.71827542 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.70354638 |
| 31 | MP0006082_CNS_inflammation | 1.69845872 |
| 32 | MP0003724_increased_susceptibility_to | 1.69561612 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.68476975 |
| 34 | MP0002405_respiratory_system_inflammati | 1.68034181 |
| 35 | MP0000569_abnormal_digit_pigmentation | 1.67976123 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.67018027 |
| 37 | * MP0002398_abnormal_bone_marrow | 1.66914823 |
| 38 | MP0003448_altered_tumor_morphology | 1.61131990 |
| 39 | MP0002006_tumorigenesis | 1.59464811 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.58577824 |
| 41 | MP0004883_abnormal_blood_vessel | 1.55505475 |
| 42 | * MP0000716_abnormal_immune_system | 1.54977746 |
| 43 | MP0002254_reproductive_system_inflammat | 1.54500344 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.51166518 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.49316297 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.48655740 |
| 47 | MP0001853_heart_inflammation | 1.48207139 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.46470500 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.45294261 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.42839829 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.39799932 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.39799932 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.38483918 |
| 54 | MP0001873_stomach_inflammation | 1.37372705 |
| 55 | MP0005164_abnormal_response_to | 1.36770487 |
| 56 | MP0002132_abnormal_respiratory_system | 1.36646980 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.35293022 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.34352379 |
| 59 | * MP0002722_abnormal_immune_system | 1.34110343 |
| 60 | * MP0002429_abnormal_blood_cell | 1.32939153 |
| 61 | MP0003828_pulmonary_edema | 1.32510913 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.32475233 |
| 63 | MP0000858_altered_metastatic_potential | 1.31675136 |
| 64 | MP0003866_abnormal_defecation | 1.27152061 |
| 65 | MP0001851_eye_inflammation | 1.22539436 |
| 66 | MP0003075_altered_response_to | 1.21858050 |
| 67 | MP0009840_abnormal_foam_cell | 1.21073713 |
| 68 | MP0005023_abnormal_wound_healing | 1.19275313 |
| 69 | MP0004381_abnormal_hair_follicle | 1.18700751 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.17167702 |
| 71 | MP0003091_abnormal_cell_migration | 1.14369105 |
| 72 | MP0008004_abnormal_stomach_pH | 1.13624657 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.12208040 |
| 74 | * MP0000703_abnormal_thymus_morphology | 1.05078173 |
| 75 | MP0000490_abnormal_crypts_of | 1.04321537 |
| 76 | MP0003690_abnormal_glial_cell | 1.03362462 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.02387626 |
| 78 | MP0008469_abnormal_protein_level | 1.02303558 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 1.02164037 |
| 80 | MP0005310_abnormal_salivary_gland | 1.01462158 |
| 81 | MP0003172_abnormal_lysosome_physiology | 1.00449085 |
| 82 | MP0000343_altered_response_to | 1.00394008 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.98811478 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.96042798 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.95836207 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.94721663 |
| 87 | MP0000371_diluted_coat_color | 0.94050924 |
| 88 | MP0000733_abnormal_muscle_development | 0.93638711 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.92630870 |
| 90 | MP0001879_abnormal_lymphatic_vessel | 0.90126934 |
| 91 | MP0003045_fibrosis | 0.88843189 |
| 92 | MP0002933_joint_inflammation | 0.86134749 |
| 93 | MP0001958_emphysema | 0.82992833 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.81977683 |
| 95 | MP0009763_increased_sensitivity_to | 0.81731042 |
| 96 | MP0002009_preneoplasia | 0.81529106 |
| 97 | MP0001915_intracranial_hemorrhage | 0.81524507 |
| 98 | MP0000604_amyloidosis | 0.80224834 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.78222102 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.77684183 |
| 101 | MP0005409_darkened_coat_color | 0.77025582 |
| 102 | MP0000350_abnormal_cell_proliferation | 0.76836103 |
| 103 | MP0003077_abnormal_cell_cycle | 0.75891860 |
| 104 | MP0006054_spinal_hemorrhage | 0.75885876 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.75212114 |
| 106 | MP0009764_decreased_sensitivity_to | 0.75100125 |
| 107 | MP0003795_abnormal_bone_structure | 0.74869196 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.74002176 |
| 109 | MP0005388_respiratory_system_phenotype | 0.72837023 |
| 110 | MP0002133_abnormal_respiratory_system | 0.72837023 |
| 111 | * MP0002086_abnormal_extraembryonic_tissu | 0.72777581 |
| 112 | MP0000249_abnormal_blood_vessel | 0.72591537 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.72042901 |
| 114 | MP0003279_aneurysm | 0.72038724 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.71630736 |
| 116 | MP0000609_abnormal_liver_physiology | 0.69544074 |
| 117 | MP0005390_skeleton_phenotype | 0.69538565 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.69495256 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.69290913 |
| 120 | MP0005166_decreased_susceptibility_to | 0.68725797 |
| 121 | MP0004130_abnormal_muscle_cell | 0.67311425 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.65007133 |
| 123 | MP0005621_abnormal_cell_physiology | 0.64785084 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.64533628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.64142251 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.57221911 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.24407916 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 3.76932058 |
| 5 | Hematochezia (HP:0002573) | 3.66022720 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.34312380 |
| 7 | Keratoconjunctivitis sicca (HP:0001097) | 3.34167237 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.33161483 |
| 9 | Recurrent viral infections (HP:0004429) | 3.29779555 |
| 10 | Cellulitis (HP:0100658) | 3.13638542 |
| 11 | Disinhibition (HP:0000734) | 3.11529910 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.10343396 |
| 13 | Colitis (HP:0002583) | 3.03242928 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.00588036 |
| 15 | Pustule (HP:0200039) | 2.98163288 |
| 16 | Keratoconjunctivitis (HP:0001096) | 2.97822095 |
| 17 | Myositis (HP:0100614) | 2.95978426 |
| 18 | Myocardial infarction (HP:0001658) | 2.93581681 |
| 19 | Amyloidosis (HP:0011034) | 2.93469172 |
| 20 | Abnormality of macrophages (HP:0004311) | 2.89627837 |
| 21 | Encephalitis (HP:0002383) | 2.89236880 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 2.82547117 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81923659 |
| 24 | Peritonitis (HP:0002586) | 2.78803505 |
| 25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.76945203 |
| 26 | Recurrent skin infections (HP:0001581) | 2.74875187 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.73285928 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 2.69081351 |
| 29 | Osteolytic defects of the hand bones (HP:0009699) | 2.68015548 |
| 30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.68015548 |
| 31 | Hemoptysis (HP:0002105) | 2.67371837 |
| 32 | Prolonged bleeding time (HP:0003010) | 2.67252117 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61888082 |
| 34 | Cerebral aneurysm (HP:0004944) | 2.60568500 |
| 35 | Gingivitis (HP:0000230) | 2.57394388 |
| 36 | Nasal polyposis (HP:0100582) | 2.56086308 |
| 37 | Periodontitis (HP:0000704) | 2.55867942 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.55457816 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.54949755 |
| 40 | Epistaxis (HP:0000421) | 2.45841100 |
| 41 | Stomatitis (HP:0010280) | 2.42251463 |
| 42 | Episodic fever (HP:0001954) | 2.42084804 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.41344376 |
| 44 | Orchitis (HP:0100796) | 2.38852003 |
| 45 | Chronic otitis media (HP:0000389) | 2.34344875 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.33841476 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.33283951 |
| 48 | Osteomyelitis (HP:0002754) | 2.33186815 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32671481 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32671481 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.32371403 |
| 52 | Vasculitis (HP:0002633) | 2.28517247 |
| 53 | Pulmonary embolism (HP:0002204) | 2.28049807 |
| 54 | Abnormality of the peritoneum (HP:0002585) | 2.25603031 |
| 55 | Esophageal varix (HP:0002040) | 2.24990027 |
| 56 | Thick nail (HP:0001805) | 2.24003838 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.21310929 |
| 58 | Arterial thrombosis (HP:0004420) | 2.20465196 |
| 59 | Emphysema (HP:0002097) | 2.18838572 |
| 60 | Slow saccadic eye movements (HP:0000514) | 2.18423022 |
| 61 | Granulocytopenia (HP:0001913) | 2.17957324 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16331116 |
| 63 | Obstructive lung disease (HP:0006536) | 2.16331116 |
| 64 | Persistence of primary teeth (HP:0006335) | 2.12812210 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.11435376 |
| 66 | Gangrene (HP:0100758) | 2.11390570 |
| 67 | Meningitis (HP:0001287) | 2.11015144 |
| 68 | Increased IgE level (HP:0003212) | 2.10101673 |
| 69 | Prostate neoplasm (HP:0100787) | 2.09976999 |
| 70 | Anorexia (HP:0002039) | 2.08664819 |
| 71 | Agnosia (HP:0010524) | 2.07411459 |
| 72 | Glomerulopathy (HP:0100820) | 2.07349549 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.07322444 |
| 74 | Verrucae (HP:0200043) | 2.06879840 |
| 75 | Papilloma (HP:0012740) | 2.06879840 |
| 76 | IgM deficiency (HP:0002850) | 2.05468733 |
| 77 | Leukocytosis (HP:0001974) | 2.04234848 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03903601 |
| 79 | Fatigue (HP:0012378) | 1.99142313 |
| 80 | Spinal cord lesions (HP:0100561) | 1.98650272 |
| 81 | Syringomyelia (HP:0003396) | 1.98650272 |
| 82 | Retrobulbar optic neuritis (HP:0100654) | 1.96998391 |
| 83 | Optic neuritis (HP:0100653) | 1.96998391 |
| 84 | Abnormality of the endocardium (HP:0004306) | 1.96245809 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95864211 |
| 86 | Abnormality of the pleura (HP:0002103) | 1.94283530 |
| 87 | Sepsis (HP:0100806) | 1.93466152 |
| 88 | Abnormality of T cell physiology (HP:0011840) | 1.92452318 |
| 89 | Aortic aneurysm (HP:0004942) | 1.92345218 |
| 90 | Abnormality of T cell number (HP:0011839) | 1.91821473 |
| 91 | T lymphocytopenia (HP:0005403) | 1.91081684 |
| 92 | Hypochromic anemia (HP:0001931) | 1.88818409 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 1.87181942 |
| 94 | Eosinophilia (HP:0001880) | 1.87132038 |
| 95 | Subacute progressive viral hepatitis (HP:0006572) | 1.85589416 |
| 96 | Large earlobe (HP:0009748) | 1.85347760 |
| 97 | Pulmonary infiltrates (HP:0002113) | 1.84200755 |
| 98 | Viral hepatitis (HP:0006562) | 1.82701279 |
| 99 | Gingival bleeding (HP:0000225) | 1.82446829 |
| 100 | Abnormal platelet volume (HP:0011876) | 1.82038956 |
| 101 | Polycythemia (HP:0001901) | 1.81294542 |
| 102 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.80567687 |
| 103 | Glomerulonephritis (HP:0000099) | 1.80040699 |
| 104 | Skin ulcer (HP:0200042) | 1.79860240 |
| 105 | Cheilitis (HP:0100825) | 1.79237441 |
| 106 | Urticaria (HP:0001025) | 1.78946452 |
| 107 | Polygenic inheritance (HP:0010982) | 1.78609732 |
| 108 | Dilatation of the ascending aorta (HP:0005111) | 1.78290400 |
| 109 | Mitral valve prolapse (HP:0001634) | 1.76648827 |
| 110 | Panhypogammaglobulinemia (HP:0003139) | 1.76084352 |
| 111 | Thrombocytosis (HP:0001894) | 1.74203697 |
| 112 | Dysostosis multiplex (HP:0000943) | 1.72966137 |
| 113 | Frequent falls (HP:0002359) | 1.72087296 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.72077109 |
| 115 | Lymphopenia (HP:0001888) | 1.71978786 |
| 116 | Increased IgM level (HP:0003496) | 1.71898028 |
| 117 | Abnormality of T cells (HP:0002843) | 1.71558791 |
| 118 | Porencephaly (HP:0002132) | 1.71502287 |
| 119 | Amaurosis fugax (HP:0100576) | 1.71274226 |
| 120 | Absent frontal sinuses (HP:0002688) | 1.69940980 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.69525245 |
| 122 | Hypochromic microcytic anemia (HP:0004840) | 1.69133846 |
| 123 | Metaphyseal cupping (HP:0003021) | 1.66437966 |
| 124 | Bicuspid aortic valve (HP:0001647) | 1.65862633 |
| 125 | Increased serum ferritin (HP:0003281) | 1.65724511 |
| 126 | Loss of speech (HP:0002371) | 1.65536273 |
| 127 | Restrictive lung disease (HP:0002091) | 1.65378465 |
| 128 | IgA deficiency (HP:0002720) | 1.65248942 |
| 129 | Striae distensae (HP:0001065) | 1.64823814 |
| 130 | Gastrointestinal carcinoma (HP:0002672) | 1.64786413 |
| 131 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.64786413 |
| 132 | Increased density of long bones (HP:0006392) | 1.63339365 |
| 133 | Spondylolisthesis (HP:0003302) | 1.63114701 |
| 134 | Nephritis (HP:0000123) | 1.62649208 |
| 135 | Ulnar bowing (HP:0003031) | 1.62454854 |
| 136 | Chest pain (HP:0100749) | 1.62234945 |
| 137 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.61025834 |
| 138 | Conjunctival telangiectasia (HP:0000524) | 1.60885554 |
| 139 | Autoimmune hemolytic anemia (HP:0001890) | 1.57849845 |
| 140 | Mucopolysacchariduria (HP:0008155) | 1.57482965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.62425320 |
| 2 | MAP4K1 | 3.02550451 |
| 3 | TYK2 | 2.69582380 |
| 4 | MAP3K14 | 2.61227626 |
| 5 | CDK12 | 2.44658178 |
| 6 | STK10 | 2.36690291 |
| 7 | MAP3K10 | 2.34436140 |
| 8 | TGFBR2 | 2.30689855 |
| 9 | TBK1 | 2.16217638 |
| 10 | TRIB3 | 2.14777652 |
| 11 | ERN1 | 2.01958444 |
| 12 | IKBKB | 2.00550918 |
| 13 | JAK3 | 2.00533716 |
| 14 | FES | 1.97040863 |
| 15 | PKN2 | 1.94988627 |
| 16 | BLK | 1.74074495 |
| 17 | FGFR4 | 1.71608536 |
| 18 | PTK6 | 1.65517609 |
| 19 | IKBKE | 1.63875069 |
| 20 | EPHB1 | 1.61263950 |
| 21 | JAK1 | 1.61114131 |
| 22 | ZAP70 | 1.59348892 |
| 23 | TTN | 1.58875860 |
| 24 | DMPK | 1.58030248 |
| 25 | FGFR3 | 1.53110169 |
| 26 | CSK | 1.51472422 |
| 27 | RPS6KA4 | 1.51270099 |
| 28 | IRAK4 | 1.49283369 |
| 29 | RIPK1 | 1.47513082 |
| 30 | MAP2K3 | 1.44897956 |
| 31 | IRAK1 | 1.44169411 |
| 32 | CSF1R | 1.40761484 |
| 33 | LRRK2 | 1.40395162 |
| 34 | CHUK | 1.40365793 |
| 35 | BMPR2 | 1.38394662 |
| 36 | ITK | 1.35898631 |
| 37 | RIPK4 | 1.34851321 |
| 38 | MAP3K1 | 1.33829661 |
| 39 | KSR2 | 1.33155710 |
| 40 | FLT3 | 1.32895405 |
| 41 | KIT | 1.32586157 |
| 42 | PIM1 | 1.31654393 |
| 43 | CDK6 | 1.29567346 |
| 44 | MAP3K13 | 1.27096787 |
| 45 | YES1 | 1.25960564 |
| 46 | EEF2K | 1.25916799 |
| 47 | IRAK2 | 1.25550422 |
| 48 | GRK6 | 1.22856273 |
| 49 | MAP3K3 | 1.20033401 |
| 50 | TNK2 | 1.18098777 |
| 51 | HCK | 1.17097174 |
| 52 | MAP3K6 | 1.12083244 |
| 53 | CAMK1D | 1.11995667 |
| 54 | MARK2 | 1.10159375 |
| 55 | IRAK3 | 1.08658448 |
| 56 | SIK3 | 1.07832472 |
| 57 | PAK4 | 1.05586350 |
| 58 | EPHA3 | 1.05464767 |
| 59 | MAPK7 | 1.04231823 |
| 60 | NEK9 | 1.03735770 |
| 61 | MARK3 | 1.02810801 |
| 62 | STK3 | 1.00476962 |
| 63 | ALK | 0.98169417 |
| 64 | BTK | 0.97883921 |
| 65 | STK4 | 0.97072062 |
| 66 | JAK2 | 0.96925284 |
| 67 | TAOK2 | 0.95301166 |
| 68 | NEK2 | 0.92204430 |
| 69 | MAP3K2 | 0.91895840 |
| 70 | LCK | 0.91149109 |
| 71 | TXK | 0.90259837 |
| 72 | CDK9 | 0.89151572 |
| 73 | SMG1 | 0.87475249 |
| 74 | CDK4 | 0.85031456 |
| 75 | SYK | 0.82910899 |
| 76 | EPHA2 | 0.81352726 |
| 77 | PDGFRB | 0.79919964 |
| 78 | PIK3CG | 0.79404450 |
| 79 | PDK1 | 0.79066965 |
| 80 | PDPK1 | 0.78463213 |
| 81 | MAP3K11 | 0.78301051 |
| 82 | MAP3K7 | 0.76360983 |
| 83 | PRKD2 | 0.76155581 |
| 84 | CDC42BPA | 0.75929944 |
| 85 | SGK3 | 0.75020859 |
| 86 | BMX | 0.73618168 |
| 87 | TEC | 0.71651676 |
| 88 | SCYL2 | 0.71608998 |
| 89 | MAP3K8 | 0.71305833 |
| 90 | MAPK12 | 0.70912651 |
| 91 | MST4 | 0.68513955 |
| 92 | CAMK1G | 0.66630198 |
| 93 | TAOK3 | 0.65333913 |
| 94 | MOS | 0.64845887 |
| 95 | BRD4 | 0.64120786 |
| 96 | NLK | 0.63716273 |
| 97 | FGR | 0.63420622 |
| 98 | EGFR | 0.62634211 |
| 99 | MELK | 0.61211721 |
| 100 | RET | 0.60471803 |
| 101 | NME2 | 0.59705632 |
| 102 | RPS6KL1 | 0.59430960 |
| 103 | RPS6KC1 | 0.59430960 |
| 104 | MAP3K5 | 0.58666417 |
| 105 | MAP2K2 | 0.56244221 |
| 106 | LATS1 | 0.55959791 |
| 107 | DYRK1B | 0.55119011 |
| 108 | TGFBR1 | 0.53742989 |
| 109 | SGK2 | 0.52735288 |
| 110 | RPS6KB2 | 0.52051063 |
| 111 | LYN | 0.51747523 |
| 112 | * MTOR | 0.49641038 |
| 113 | KSR1 | 0.48875600 |
| 114 | WNK1 | 0.48146015 |
| 115 | NUAK1 | 0.47818333 |
| 116 | MAPKAPK2 | 0.47518789 |
| 117 | RAF1 | 0.47498392 |
| 118 | FYN | 0.46476037 |
| 119 | TRPM7 | 0.45952438 |
| 120 | ABL1 | 0.45916105 |
| 121 | SIK2 | 0.45782263 |
| 122 | RPS6KA6 | 0.45776684 |
| 123 | ICK | 0.42346288 |
| 124 | MAPK15 | 0.42282416 |
| 125 | MATK | 0.40963217 |
| 126 | PDGFRA | 0.40607285 |
| 127 | TAOK1 | 0.40275225 |
| 128 | PAK2 | 0.39152332 |
| 129 | HIPK2 | 0.37592564 |
| 130 | SIK1 | 0.37110026 |
| 131 | * GSK3A | 0.36558566 |
| 132 | CLK1 | 0.35831782 |
| 133 | STK24 | 0.34661313 |
| 134 | RPS6KA5 | 0.34100058 |
| 135 | INSR | 0.33692283 |
| 136 | PRKAA2 | 0.33688399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62115719 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53514650 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52445774 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.41992612 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11412550 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06003777 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99834277 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.88865938 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86199104 |
| 10 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.83848180 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76604346 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73508989 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.64449088 |
| 14 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58964466 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57680431 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56400035 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55549640 |
| 18 | * Apoptosis_Homo sapiens_hsa04210 | 1.54771359 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54465692 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.53536056 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53397452 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53329269 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.53181204 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52091973 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.49695649 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.45350950 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44510557 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42530536 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41093095 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39711233 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.38947078 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.37786644 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.37477711 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.33835040 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30743750 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30212614 |
| 37 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26960356 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26773979 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25542052 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23814092 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.20821545 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.19211039 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19098661 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.10904393 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09314356 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09082364 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.08854980 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05062442 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00355223 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98829640 |
| 51 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98296225 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.97341161 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96727031 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.92395376 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.92318289 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.92173157 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91773757 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.90235406 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89419871 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89353660 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89024851 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.87932115 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87529159 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84156176 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83217764 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82679959 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82065303 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81982388 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81452631 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80058140 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79751392 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79221351 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.79030489 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78940118 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78376487 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78211798 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76759109 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73673951 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.73493309 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.73284877 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72104026 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71212183 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70938374 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70778343 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69990196 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68901720 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65782517 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64293833 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63860799 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63481560 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.62422277 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.58472436 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57707940 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56167138 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55806712 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.55412979 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54636902 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.54104108 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53631606 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53031815 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52469631 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52443030 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52099087 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51856606 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51132792 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50615115 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49738628 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49047702 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48599182 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.48285742 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45332908 |
| 112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44357264 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42653138 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41699950 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41580456 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41505170 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41435503 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40806643 |

